[The anti-tetanus serumprophylaxis (author's transl)].
The antitoxin titre against tetanus toxin has been evaluated in wounded subjects before and 24 after anti-tetanus serumprophylaxis by passive haemagglutination. Treatment with digested heterologous antiserum (3000-6000 I.U.) or with human hyperimmune immunoglobulins does not modify preexisting antitoxin titre. Serum negative subjects remain as such.
D000917:Antibody Formation; D005260:Female; D006801:Humans; D007106:Immune Sera; D007136:Immunoglobulins; D008297:Male; D013742:Tetanus / Q000276:immunology / Q000517:prevention & control; D013745:Tetanus Toxoid / Q000627:therapeutic use*
D007106:Immune Sera; D007136:Immunoglobulins; D013745:Tetanus Toxoid
Sulla sieroprofilassi antitetanica